>>Description of the research protocol "Nivolumab"

Nivolumab en Aide d'urgence hors remboursement
Phase MNP study| Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Oncologie générale
Brugmann identifier : Nivolumab

Resources

Involved department : Hemato-oncology
Principal investigator : Lecomte
Sponsor : BMS
Contact : Clinical Research Unit